| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |